INO · Inovio Pharmaceuticals, Inc. · Short Volume
$0.93
+0.04 (+4.34%)
At close · Oct 28
View the 10-K filed Mar 12, 2026
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We do not currently have sufficient working capital to fund our planned operations for the next twelve months and substantial doubt exists as to our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Customer concentration
— key customers 100% of revenue
Key customers — 100% of revenue (the years ended December 31, 2025 and 2024)
“During the years ended December 31, 2025 and 2024, we derived 100% of our revenue from ApolloBio.”
Market Cap
$92.02M
Shares
103.40M
Volume · Oct 28
4.57M
Avg daily vol (3M)
4.53M
Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.
Short Volume
| Date | Short Volume | Short Exempt | Total Volume | Short % |
|---|---|---|---|---|
| 2026-10-28 | 944,041 | 9,400 | 2,983,976 | 31.6% |
| 2026-10-27 | 628,613 | 0 | 2,293,607 | 27.4% |
| 2026-10-26 | 609,846 | 1,000 | 1,714,354 | 35.6% |
| 2026-10-23 | 541,266 | 0 | 2,198,055 | 24.6% |
| 2026-10-22 | 1,357,048 | 327,957 | 3,628,307 | 37.4% |
| 2026-10-21 | 2,029,721 | 282,955 | 6,330,400 | 32.1% |
| 2026-10-20 | 338,339 | 1,486 | 1,448,151 | 23.4% |
| 2026-10-19 | 425,349 | 100 | 1,528,005 | 27.8% |
| 2026-10-16 | 564,507 | 0 | 1,362,155 | 41.4% |
| 2026-10-15 | 375,638 | 1,619 | 1,084,941 | 34.6% |
| 2026-10-14 | 611,822 | 201,366 | 1,770,538 | 34.6% |
| 2026-10-13 | 1,765,679 | 305,323 | 5,410,329 | 32.6% |
| 2026-10-12 | 412,088 | 0 | 1,028,049 | 40.1% |
| 2026-10-09 | 630,776 | 625 | 1,437,904 | 43.9% |
| 2026-10-08 | 532,093 | 0 | 1,145,456 | 46.5% |
| 2026-10-07 | 768,410 | 2,454 | 1,485,028 | 51.7% |
| 2026-10-06 | 467,700 | 988 | 1,122,304 | 41.7% |
| 2026-10-05 | 662,141 | 800 | 1,486,246 | 44.6% |
| 2026-10-02 | 530,941 | 120 | 1,491,817 | 35.6% |
| 2026-10-01 | 405,158 | 0 | 1,039,326 | 39.0% |
| 2026-09-30 | 612,493 | 17,245 | 1,197,892 | 51.1% |
| 2026-09-29 | 556,308 | 812 | 1,324,051 | 42.0% |
| 2026-09-28 | 291,393 | 1,200 | 1,091,939 | 26.7% |
| 2026-09-25 | 469,491 | 1,200 | 1,358,024 | 34.6% |
| 2026-09-24 | 635,966 | 984 | 1,831,207 | 34.7% |
| 2026-09-23 | 749,192 | 2,431 | 1,803,336 | 41.5% |
| 2026-09-22 | 634,319 | 2,617 | 1,595,871 | 39.7% |
| 2026-09-21 | 597,562 | 7,091 | 1,535,438 | 38.9% |
| 2026-09-18 | 262,993 | 200 | 718,325 | 36.6% |
| 2026-09-17 | 457,738 | 1,412 | 1,222,758 | 37.4% |
| 2026-09-16 | 740,016 | 7,500 | 1,953,142 | 37.9% |
| 2026-09-15 | 550,131 | 0 | 1,479,283 | 37.2% |
| 2026-09-14 | 379,273 | 1,865 | 1,485,331 | 25.5% |
| 2026-09-11 | 446,146 | 52 | 1,313,914 | 34.0% |
| 2026-09-10 | 442,816 | 6,298 | 1,155,028 | 38.3% |
| 2026-09-09 | 400,972 | 1,255 | 1,055,131 | 38.0% |
| 2026-09-08 | 525,878 | 13,193 | 1,693,648 | 31.0% |
| 2026-09-04 | 544,988 | 21,641 | 1,316,952 | 41.4% |
| 2026-09-03 | 616,047 | 2,408 | 1,538,999 | 40.0% |
| 2026-09-02 | 785,763 | 0 | 2,314,646 | 33.9% |
| 2026-09-01 | 281,187 | 3,572 | 1,168,509 | 24.1% |
| 2026-08-31 | 1,628,439 | 4,000 | 3,239,782 | 50.3% |
| 2026-08-28 | 327,100 | 3,099 | 1,011,912 | 32.3% |
| 2026-08-27 | 408,815 | 4,982 | 1,284,493 | 31.8% |
| 2026-08-26 | 566,369 | 229 | 1,900,474 | 29.8% |
| 2026-08-25 | 666,194 | 9,364 | 2,302,609 | 28.9% |
| 2026-08-24 | 859,385 | 290 | 2,516,949 | 34.1% |
| 2026-08-21 | 641,763 | 4,230 | 2,713,256 | 23.7% |
| 2026-08-20 | 848,007 | 2,750 | 2,244,866 | 37.8% |
| 2026-08-19 | 997,582 | 100 | 2,797,783 | 35.7% |
Showing 1–50 of 65 days
Key facts
CIK
1055726
CUSIP
45773H409
13F (30d)
22 filings
22 filers
Visit website
Investor relations